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TRANSPEPTIDASI BERANTARAKAN SORTASE: APLIKASI SORTASE A 
SEBAGAI ALAT MODIFIKASI SETEMPAT UNTUK ANTIBODI 
REKOMBINAN 
 
ABSTRAK 
 
Diagnostik ‘point-of-care’ (POC) untuk kawasan terpencil telah menjadi cabaran 
besar untuk memerangi penyakit berjangkit di seluruh dunia. Pembangunan kaedah 
untuk membantu proses pembangunan diagnostik POC baru adalah penting untuk 
memperbaiki senario penjagaan kesihatan di seluruh dunia. Format utama POC asai 
adalah pengesanan interaksi antibodi- antigen . Untuk mencapai matlamat ini, asai 
yang mampu melaporkan interaksi antara antibodi dan antigen adalah diperlukan. 
Kebiasaannya. asai dibangunkan dengan  merangkaikan antibodi-antibodi kepada 
satu pelapor yang spesifik seperti enzim atau protein. Projek ini menerangkan 
penggunaan transpeptidasi berantarakan sortase sebagai satu cara untuk 
merangkaikan antibodi rekombinan untuk sepasang protein pelapor. Enzim Sortase 
adalah unik dengan mengenali motif yang mempunyai urutan yang khusus untuk 
membenarkan tidak balas rangkaian protein-protein secara setempat. Disebabkan 
sifatnya yang spesifik, ianya mempunyai kelebihan untuk digunakan untuk 
biokonjugat terutamanya dalam membangunkan platform asai diagnostik. 
SrtA(0.546kb) telah diekstrak daripada Staphyococcus aureus  dan diklon dalam 
sistem pRSET dibawah kawalan T7 promoter. Satu set motif telah digabungkan, 
diklon dan diekspres untuk memilih motif paling efisien pada satu kondisi yang 
dioptimumkan. Satu eksperimen pembuktian-konsep telah dijalankan menggunakan 
anti-ubiquitin scFv (0.72kb) sebagai protein motif penderma (LPXTG motif). 
Disamping itu, protein hijau pendarfluor (eGFP) (0.714kb) dan invertase (1.236kb) 
xviii 
 
telah dipilih sebagai protein motif penerima (motif glisin) yang berfungsi sebagai 
sistem pelapor. Strategi penulenan tag berganda telah dibangunkan untuk 
meningkatkan hasil penulenan produk konjugat. Pembangunan dua platform yang 
berbeza menggunakan dua protein pelapor yang berbeza telah digunakan. Kajian 
awal telah dijalankan dengan menggunakan eGFP untuk aplikasi pada platform 
immunoassay pendarfluor. Selepas mengoptimumkan keadaan ideal, satu proses 
konjugasi kedua telah dibangunkan untuk enzim invertase. Konjugasi untuk invertase 
akan membolehkan pembangunan asai antibodi-antigen yang pesat menggunakan 
meter glukosa peribadi (PGM). Invertase konjugat akan berfungsi untuk 
menghasilkan bacaan di PGM dengan kehadiran glukosa. Proses konjugasi 
berantarakan sortase di platform PGM membenarkan pembangunan asai POC yang 
mudah dan cepat. Ini memberi alternatif yang menarik untuk pembangunan antibodi 
- antigen asai yang menggunakan PGM untuk aplikasi POC. 
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SORTASE-MEDIATED TRANSPEPTIDATION: THE APPLICATION OF 
SORTASE A AS A TOOL FOR SITE-SPECIFIC MODIFICATION OF 
RECOMBINANT ANTIBODIES 
 
ABSTRACT 
 
Point-of-care (POC) diagnostics for resource deprived regions remains a major 
challenge to combat infectious diseases worldwide. Development of new methods to 
aid the development process of new POC diagnostics is essential to improve the 
healthcare scenario worldwide. The major format of POC assay is the detection of 
antibody-antigen interaction. To achieve this, an assay is required to be capable of 
reporting the interaction between the antibody and antigen. In most common assays, 
these detection are achieved by conjugating antibodies to specific reporter molecules 
such as enzymes or proteins. The work describes the application of sortase mediated 
transpeptidation as a means to conjugate recombinant antibodies to a pair of reporter 
proteins. Sortase enzymes are unique in a way that they recognized a specific 
sequence motif for reaction allowing a site-specific conjugation of proteins. Due to 
this specificity, they are very beneficial to be used for bioconjugation mainly in 
developing diagnostic assay platforms. SrtA (0.546kb) was isolated from 
Staphylococcus aureus and cloned inside pRSET system under a tight control of T7 
promoter. A set of motif were also fused, cloned and expressed to select the most 
efficient motif at an optimized condition. A proof-of-concept experiment was 
conducted by using the anti-ubiquitin scFv(0.72kb)  as a donor motif (LPXTG motif) 
protein. Meanwhile, enhanced green fluorescent protein (eGFP)(0.714kb) and 
invertase(1.236kb) were chosen as the receiver motif (glycine motif) protein 
functioning as the reporter system. A double tag purification strategy was developed 
xx 
 
to improve purification yield of the conjugated product. Development of two 
different platforms utilizing two different reporter proteins was used. Initial 
investigation was carried out using eGFP for application on a fluorescent 
immunoassay platform. After optimizing the ideal conditions, a second conjugation 
process was developed for invertase enzyme. The conjugation to invertase allowed 
for rapid development of antibody-antigen assays detectable using a personal glucose 
meter (PGM). The function of conjugated invertase was to generate a readout on the 
PGM in the presence of glucose. The sortase mediated conjugation process allows 
for an easy and rapid development of recombinant antibody derived POC assays on 
the PGM platform. This would provide an interesting alternative for the development 
of antibody-antigen assays utilizing a PGM for POC applications. 
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CHAPTER 1: INTRODUCTION 
1.1 General Introduction 
The evolution of diagnostics and treatment of diseases has become easier with the 
expansion of molecular biology approaches. Immunoassays are widely used for 
preliminary detection of the presence of diseases via antigen-antibody interaction in 
order to initiate the faster treatments. To bring these complexes towards detectable 
ranges, commercial antibodies against diseases are commonly fused to a detection 
module. The signals from these modules are taken to determine the presence of that 
particular disease biomarker. In a simple explanation, immunoassay is made up of 
two vital components; the binder and the reporter. The main characteristic of the 
reporter is their ability to generate signals and how high their sensitivity is so that the 
complex is well represented. Meanwhile, antibodies in various formats are used to 
bind the specific antigens with good specificity. As immunoassay is a simple and 
rapid test, antibody tagging is the most practical method used to develop molecular 
based diagnostic (H. T. Ta et al., 2011).  
Antibody tagging is generally developed by two methods, either by 
bioconjugation or chemical modification. Until now, chemical modifications are 
universally used as the tagging reaction. In this format, reactive functional groups are 
commonly utilized (Yin Zhang et al., 2011). There are three types of conventional 
chemical modifications that are actively used; NHS ester-maleimide-mediated 
conjugations with heterobifuctional cross linker containing both amine-reactive NHS 
ester and sulfydryl-reactive maleimide (Dai et al., 2013), glutaraldehyde mediated 
conjugation with stable secondary amine linkages between two proteins (Tresca et 
al., 1995) , and reductive amination-mediated conjugation where aldehyde groups are 
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conjugated with amine- or hydrazide-containing molecules by reductive amination 
(Carmenate et al., 2004). These three methods are the cornerstone of many 
bioconjugation processes for diagnostic applications. In commercialized diagnostic 
kits, antibodies used are often conjugated to horseradish peroxidase (HRP) or 
alkaline phosphatase (AP) which catalyses the substrates such as 3,3’,5,5’-
tetramethylbenzidine(TMB) and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic 
acid)  (ABTS) to result in colour formation which in turn is  translated as signals 
readouts (Grandke et al., 2013). The conjugation of the kit components relies on the 
three methods mentioned earlier. Amine or carboxylate groups are generally 
involved as the cross linking reagent. Although these methods are widely used, the 
major downfall is that it occurs in a random orientation and thus increases the 
possibility of blocking the antigen binding sites on an antibody molecule. Besides, 
variation from batch to batch production and low recovery yields makes it not cost 
effective.  
As an alternative to the chemical modifications, several approaches have been 
highlighted to make the production of recombinant antibodies faster and easier (Hu 
et al., 2013). Due to the increasing interest in recombinant DNA technology, 
modifications are easily introduced at genetic level thus allowing various genetic 
fusions to antibodies. Bacterial expression system is commonly favoured since this 
system is easy to be utilized and at the same time gave high protein yields. However, 
this method is limited only to protein-protein conjugation and does not allow 
conjugation to surfaces and particles. As the conjugation of antibody to nanoparticles 
is greatly improved over the years, this has allowed for antibody conjugated particles 
to be widely used for therapy and diagnostics (Omidfar et al., 2013).  
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The other alternative that is constantly being studied is the application of 
biological enzyme in antibody tagging process. These biological enzymes are usually 
site-specific and are able to initiate modification on selected functional groups 
available thus generating new bonds between two molecules. The advantages of this 
processes includes completely different proteins to be fused together via site directed 
coupling and polymeric protein assembling  without disrupting the function of the 
fusion components. These type of protein fusion are often affected by various factor 
for example temperatures, pH, oxidizing condition and enzyme catalysis (Gerrard, 
2002). Groups of enzymes catalysing the fusion include transferases, hydrolases and 
oxidoreductases. In this study, Sortase A from the transpeptidase family will be used 
to develop an immunoassay platform using this biological enzymatic reaction.  
The developed approach was applied to develop a diagnostic test mainly for 
point-of-care (POC) application. To this effect, the personal glucose meter (PGM) 
being easy to use and readily available was demonstrated to meet this aim. This type 
of electrochemical biosensor has been widely studied to detect other molecules 
besides blood gas in recent years. Looking forward to the future of simplified test 
assays, PGM offers an easy universal in-home detection platform for the detection of 
multiple diseases. Therefore, to develop a detection system using PGM, invertase 
was used as the key reporter enzyme. Invertase is an enzyme which catalyses the 
conversion of sucrose to glucose. The PGM detection system is a strict process 
where it only detects the same conformation of glucose so false positive results are 
reduced. Therefore, conjugation of antibodies to invertase via sortase A mediated 
conjugation mechanism was invetigated to ensure the conjugation process did not 
alter the functionality of the enzyme as well as the antibody to function on the PGM 
for detection applications.  
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1.2 Statement of problems and rationale of study 
Since conjugation of biomolecules via chemical methods requires chemical 
modification to the proteins, inactivation of the conjugates is often the common 
concern. Being a site specific enzyme, Sortase A is a good candidate for “friendly” 
conjugation process as it does not modify the structure of the protein involved during 
the fusion reaction. Besides, it is known that the conjugation aided by a biological 
process is less harmful compared to chemical conjugation as the process involved is 
usually a replication of natural mechanism. Unlike chemical methods, the highly 
selective nature of Sortase A ensures that attachment of proteins is not done 
randomly but instead targets a specific amino acid motif. Another concern with the 
use of chemical methods is the requirement of extreme conditions that could affect 
the folding of the proteins. Sortase A conjugation has been reported to work best at 
mild conditions whereby disturbances to the integrity of the protein structure can be 
minimized. The conservation of the protein structure is important to ensure 
functionality of the protein. This will have a direct effect on the quality of assay 
developed with the conjugates. Therefore the investigation of alternative processes 
for bioconjugation of recombinant antibodies could aid to improve the generation of 
fused antibodies for use on diagnostic platforms. Taking into consideration the nature 
of Sortase A mediated transpeptidation, it could potentially be an interesting 
alternative to establish an-in house production of immunoassay components.  
For the detection process of immuno-complexes, a sensitive detection module 
is required in order to allow sensitive detection of the complex. Fluorescence 
proteins such as the enhanced green fluorescent protein (eGFP) and invertase are 
suitable for diagnostic applications due to their respective functions. Utilizing eGFP, 
a fluorescent based detection of antibody-antigen complexes can be accomplished. 
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This could provide an interesting alternative to the conventional chemically 
conjugated HRP and AP antibodies. eGFP is often used as biosensor due to its 
fluorescence properties which does not require activation with a chemical substrate 
to initiate a readout.  
Another biomolecule of interest as a reporter system is invertase. Invertase 
has gained a lot of interest due to its ability to induce signal production via its 
glucose conversion activity. The proposed used of it became increasingly attractive 
as its activity can be detected using a commercialized personal glucose meter (PGM) 
as reported by several groups. PGM is conventionally used to monitor blood glucose 
level in diabetic patients.  Using this idea, we improvised the use of it by detecting 
glucose level inside an antibody-antigen reaction, where invertase would function as 
the key component in producing readout. Compared to HRP and AP, invertase 
utilizes sucrose as its sole substrates to release glucose and fructose. Utilizing sortase 
A reaction to tag invertase to antibodies would provide an easier and safer 
conjugation process as it does not involve modifications to its structure hence 
preserving the functionality of both the antibody and invertase. In addition to eGFP, 
invertase is another great tool to be used for antibody-antigen detection. It is hoped 
that by utilizing the Sortase A mediated transpeptidation to conjugate antibodies to 
various reporter biomolecules, a new avenue for diagnostic detection system for 
antibody-antigen reaction can be realised.  
A streamlined process and vector series would allow easy and rapid 
substitution of disease specific recombinant antibodies or antigens for conjugation 
with invertase. This would reduce the development process of new disease sensors 
for POC application.  
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1.3 Research Objectives  
 This research was carried out to develop an immunoassay via Sortase A 
mediated transpeptidation. The approaches used consist of: 
1) Designation and generation of a family of sortase acceptor and donor vector 
for streamline antibody-protein ligation. 
2) Cloning, expression and purification of Sortase A and motifs protein 
3) Development of sortase-mediated antibody-protein ligation 
4) Evaluation of the functionality of sortase-mediated antibody for 
immunoassay 
The overview of this study was sketched out as shown in Figure 1.1 
 
Figure 1.1 : Overview of the study carried out 
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CHAPTER 2: LITERATURE REVIEW 
2.1 Transpepidases 
Transpeptidation is a process of transferring an amino acid from a peptide 
chain to another via enzyme catalysis or of a peptide chain itself. Sortase family 
members are well known transpeptidases which actively carry the transpeptidation in 
Gram positive bacteria like Staphylococcus aureus.  
 
2.1.1 Staphylococcus aureus subsp. aureus (ATCC®25923
TM
) 
Staphylococcus sp. is grouped under Micrococcaceae family. Staphylococcus aureus 
is a well-known pathogen causing various infections to human and animal. They 
usually reside on human skin, nails and nostril areas, infiltrating the inner layer of the 
host barrier and causes formation of lesions with pus all over the systems (L. A. 
Marraffini et al., 2006). Classified under Gram positive bacteria, like other members, 
its pili generation was also made by crosslinking individual units of pilin monomers 
and finally joining the polymers to the cell wall peptidoglycan via sortase enzymatic 
reaction (Mandlik et al., 2008). MSCRAMMs (microbial surface component 
recognizing adhesive matrix molecules) which are involved in the adherence of the 
bacteria to host cell during infection are also revealed to use sortase transpeptidation 
system for its binding to the cell wall peptidoglycan (Foster & Höök, 1998). Since 
sortases was revealed to be crucial for Gram positive bacteria life process, the 
interest of studies on its system increased.  
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2.1.2 Sortase superfamily  
Sortase was discovered in Gram positive bacteria with a variation of motifs. 
Generally, it is classified into three isoforms, which are SrtA, SrtB and SrtC. All the 
three isomers of sortases have different recognition motif sequence and functions. 
SrtA recognizes the LPXTG amino acid motif whereas, SrtB recognize NPQTN and 
SrtC recognize QVPTG motif (Clancy et al., 2010). SrtA is present in all Gram 
positive bacteria, meanwhile, SrtB and SrtC are discovered in selected species only. 
SrtA is mainly responsible for the pathogenesis of the bacteria where it anchors the 
protein with its signalling motif to lipid II which most of the anchored proteins are 
the virulent factors of the bacteria itself, meanwhile, SrtB is in charge of the iron 
deprivation response and SrtC act as the pilin polymerase in the bacteria.  
 In a study conducted by Weiss et al. (2004), SrtA knockout Staphylococcus 
aureus was able to greatly reduce the virulence factor to acute bacterial arthritis in 
several animal models. The absence of SrtB also gave impact to the adherence of 
pathogen to the host cell, however, the influence is lower compared to SrtA. SrtB 
plays a bigger role during later stages of infection where the environmental sources 
of iron become scarce (Jonsson et al., 2002; Manetti et al., 2007). In a deficient SrtA 
and SrtC pili-producing species, the setback are impairment of biofilm formation and 
halting the infection process (Trotonda et al., 2008).  
 Due to the importance of sortase in Gram positive bacteria infectivity, there 
has been increasing interest on making sortase an anti-infective agent. This is 
because in sortase knockout strains, the growth rates of the strains were never 
impaired by the knockout when compared with the wild-type strain. More 
importantly, the modification resulted mainly in the loss of virulence only.  
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2.2 Sortase A  
2.2.1 Background 
 Sortase A is known as a housekeeping enzyme to the Gram positive bacteria 
and exists in almost all species of pathogenic bacteria. As an important enzyme 
catalysing the attachment of virulent factors to the bacterial peptidoglycan and 
generation of pili, the deletion of it generally causes the bacteria to lose its 
pathogenicity (Jonsson et al., 2002; Manetti et al., 2007; Nallapareddy et al., 2011; 
Sabet et al., 2005). To the realization of this phenomenon, it sparked a wave of study 
on Sortase A effects in gene therapy (Maresso & Schneewind, 2008).  
 In its native environment, Sortase A catalyses the covalent linkage between 
MSCRAMMs (microbial surface component recognizing adhesive matrix molecules) 
to the lipid II on the peptidoglycan layer, in the case of Staphylococcus aureus, is the 
pentapeptide sequence which acts as the cell wall sorting signal(CWSS) (Clancy et 
al., 2010). Examples of MSCRAMMs are Protein A and fibrinogen-binding protein 
(ClfA). These MSCRAMMs which are commonly known as surface proteins are 
important for infectivity and pathogenicity of Gram positive bacteria where they 
promote the bacterial adhesion to the host and evade the immunity system (L. A. 
Marraffini et al., 2006). Protein A (spA) takes a role of binding to the Fc region of an 
immunoglobulin (IgG) and Fab regions of B-cell receptor. These phenomenon causes 
the blockage of opsonophagocytosis and death of B-cell in vitro (Kobayashi & 
DeLeo, 2013). Meanwhile, fibrinogen-binding MSCRAMMs (ClfA) are used to 
facilitate the attachment of bacteria to the plasma clots. Mutations of these 
MSCRAMMs causes the bacteria to reduce the virulence tremendously compared to 
the wild type strain (Foster & Höök, 1998). Therefore, Sortase A plays an important 
role in preserving the virulence of these bacteria.  
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2.2.2 Sortase A stucture  
Clubb and co-worker reported on the development of Sortase A structure in 2001 
(Figure 2.1). Sortase A structure from Staphylococcus aureus consist of a 206-
residue enzyme was divided into three domain with a stretch of non-polar amino 
acids signal peptide at its N-terminal (1-24 amino acid residues) which functions as 
the catalyst for its insertion in the cytoplasm (Sarkis K. Mazmanian et al., 2000) 
followed by a linker of transmembrane domain and catalytic domain (25-59 amino 
acid residue) and a catalytic domain (60-206 amino acid residue) (J. Zhu, 2010). The 
deletion of the first 59 amino acid group of the enzyme expressed in E.coli 
expression system resulted in production of a fully functional and soluble 
polypeptide in the cytoplasm of E.coli (Ilangovan et al., 2001; Hung Ton-That et al., 
1999). The affinity-purified sortase, labelled as SrtA∆N is responsible for cleaving the 
LPXTG motif between threonine and glycine, transpeptidation and peptidoglycan 
substrates. From the sortase A structure elucidated by NMR spectroscopy and x-ray 
crystallography, its backbone consists of eight stranded beta-barrel with random 
loops. These random loops termed as β2/β3, β3/β4, β6/β7 and β7/β8 strands are 
highly mobile and unstable. A conserved cysteine residue at position 184 resides in 
the β6/β7 loops (Zong et al., 2004). As a sortase class I member, sortase A meets the 
standard by containing the signature active site of the family (LXTC) (S. K. 
Mazmanian et al., 2001). This residue is believed to take part as the active site on 
stops the activity of sortase A in vitro and in vivo (Hung Ton-That et al., 2000). 
Other evidence is that when wild-type sortase was treated with hydroxylamine, the 
acyl-intermediate was resolved  thus releasing the surface protein together with the 
threonine hydroxamate at the C-terminal of the protein (Hung Ton-That et al., 1999). 
Besides, when methyl methanethiosulfonates was added, the activity of sortase A is   
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Figure 2.1 Ribbon structure of Sortase A(adopted from (Ilangovan et al., 2001)) 
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immediately stopped (Hung Ton-That & Schneewind, 1999). With the addition of 
DTT, the activity was restored. DTT is a reducing agent which generates the 
sulfhdryl active site(R-SH) important for reactivation (Hung Ton-That et al., 1999). 
The substitution of cysteine at position 184 to alanine completely abolishes the 
activity of Sortase A.  
Together with Cys
184
, His
120
 and Arg
197
 are directly involved in the substrate 
binding to the enzyme. The first proposal of His
120
 function claims that the imidazole 
ring of His
120 
may activate Cys
184
 causing the formation of thiolate followed by 
nucleophilic attack of the carbonyl group of the motif protein. In the absence of 
substrate, the side chain of Cys
184
 which are located at β6/β7 loop and His120 located 
at β2/β3 loop does not interact with each other where the side chain of Cys184 is 
projected out from His
120
 into the hydrophobic pocket. However, the recent 
evidences showed that Cys
184
 do not need activation from His
120
 to form an 
imidazolium-thiolate bond in order to attack the carbonyl group of threonine in the 
LPXTG motif. In fact, at physiologic pH, both of the residues are not charged. 
According to the proposed determination of solvent isotope effect, only a small 
number of populations are active in their ionization form (Frankel et al., 2005). 
Imidazolium ion of His
120
 is found to take part in protonation of glycine when the 
covalent bond of threonine and glycine is broken. Besides, it also takes part in the 
second phase of the mechanism; the nucleophilic attack of pentaglycine of the lipid II 
by activating the terminal amine on the glycine residue (Frankel et al., 2005; Suree et 
al., 2009). 
 Meanwhile the function of Arg
197
 is still in debates. Arg
197
 which are 
anchored in β8 existed near the Cys184 is also shown to be important structure of 
sortase A. In a proposal by Luciano A Marraffini et al. (2004), they speculate the 
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major function of Arg
197
 is for the ionization of Cys
184
 or lipid II substrates (Zong et 
al., 2004). Alanine substitution at position 197 causes a major decrement in enzyme 
activity of sortase A.(Hung Ton-That et al., 1999; H. Ton-That et al., 2002; Hung 
Ton-That et al., 2000). According to the dynamic NMR structures in the recent 
study, Arg
197
 showed potential to be a stabilizer for the oxyanion transition state of 
the formed intermediates (Suree et al., 2009).   
  Sortase A from Staphylococcus aureus is strongly dependent on the Ca
2+
 ion 
in the reaction. The LPXTG substrates are recognized by sortase A via contact with 
valine at position 166,168 and leucine at position 169 in the β6/β7 loop (Suree et al., 
2009). Upon substrate binding, the loop will undergo transition from a non-
sequential open loop to a well ordered close state loop suggesting that the binding 
will cause a conformational change to the residue position. This conformational 
change is stabilized by the Ca
2+
 ion binding to Glu
171
 in the β6/β7 loop and a residue 
at β3/β4 loop (Naik et al., 2006). Hence, substrate affinity is improved with the 
binding of Ca
2+
 ion. If low concentration of Ca
2+
 is used, the catalytic efficiency 
drops with increasing Km. Due to the strong dependency towards Ca
2+
 ion, it is 
difficult to conduct the reaction in Ca
2+ 
scarce environment and in the presence of the 
reaction inhibitor, the calcium binding compound such as phosphate, carbonate and 
EDTA(ethylenediaminetetraacetic acid) (H. Hirakawa et al., 2012). 
 
2.2.3 Sortase mediated transpeptidation 
Sortase A conducts transpeptidation in a highly specific manner. There are three 
important proteins that was involved in the sortase A transpeptidation, the enzyme; 
Sortase A, the donor motif; LPXTG motif protein and the acceptor motif; 
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pentaglycine motif. According to Clancy et al. (2010), leucine, proline, threonine and 
glycine were preferred at position 1,2,4 and 5 in the Sortase A signalling motif but it 
does not has any preference in the amino acid selection at position 3. Preceding the 
transpeptidation reaction, sortase will cleave the LPXTG motif between threonine 
and glycine residue and form a thioacyl-intermediate with the captured LPXT-motif 
protein.  
 In 1999, a model of the sortase structure predicting its active site, the 
cysteine 184(Cys
184
) was developed presenting the nucleophilic attack from sortase 
to the carbonyl group of the peptide bond of threonine and glycine, followed by the 
thioester complex formation between the interacting active sites of Cys
184
 and the 
carboxyl terminal group of threonine(Hung Ton-That et al., 1999). The cleaved 
threonine carboxyl end was then attached to the pentaglycine motif of peptidoglycan 
covalently. 
 In the absence of nucleophile, sortase starts to hydrolyse the LPETG peptide 
at the same site in a slow pace with a ping-pong mechanism. A ping-pong 
mechanism, commonly known as double displacement mechanism is characterized 
by the formation of a substrate-enzyme intermediate in the first step followed by the 
disintegration of the complex when another substrate come into contact to form the 
final product. At the end of reaction, the enzyme will return to its original state 
(Cleland, 1973). The limitation of this type of reaction is that the rate of hydrolysis of 
the acyl-enzyme is dependent on the rate of the same acyl-enzyme formation.  
 Mimicking the natural phenomenon of sortase conjugation, in vitro 
conjugation of LPXTG-motif protein and oligolycine motif protein was demonstrated 
(Popp et al., 2007; Popp et al., 2009; Theile et al., 2013). Substrate containing 
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LPXTG motif and oligoglycine (Gn) was made using the standard molecular cloning 
protocol. Glutamic acid residue is commonly chosen to be introduced at the position 
3 of the recognition motif as it is readily preferable in the native mechanism of 
sortase A (Boekhorst et al., 2005).  
 Biotin and fluorescent probes in conjugation with oligoglycine were used as 
substrates utilizing the sortase mechanism by modifying the LPETG peptide tag and 
fusing it to the C-terminal of targeted protein (Mao et al., 2004; Ranganath 
Parthasarathy et al., 2007; Tanaka et al., 2008). As an example, oligoglycine on a 
folate was used to conjugate to the GFP-containing C-terminal LPETG  tag via 
sortase reaction (Mao et al., 2004). The results shows that one to three glycine 
residues can serve as substrates for the reaction, however it is rate-limited according 
to the amount of terminal glycine it possess (Mao et al., 2004). Figure 2.2 shows the 
overall process of sortase-mediated conjugation and its chemical reaction.  
 
2.2.4 Single-chain fragment variable (scFv) as biosensors 
Antibodies are produced as a part of defensive response by vertebrate animals 
towards the harm caused by toxic materials and foreign organisms. Recombinant 
antibodies exist in various formats for example scFv, nanobodies, Fabs and 
minibodies. A commonly used antibody format for in vitro detection is the single 
chain fragment variable(scFv) which contains a variable heavy (VH) and a variable 
light( VL) chain connected by  a sequence of peptide termed as glycine-serine linker 
without the constant region of the antibodies (Bird et al., 1988; Liu et al., 2009; Zeng 
et al., 2012). It was first developed in the 1980s as an alternative to the large-sized 
natural antibody (~150kDa) (Borrebaeck & Wingren, 2011).  
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scFv is  a small form of the antibody idiotype (~27kDa) that retains the antigen 
specificity as the full antibody (Padlan, 1994). They consist of six complementary 
regions classified in three groups namely CDR1, CDR2, CDR3 which is present on 
both VH and VL. Amino acids in the CDRs are complement to the amino acids 
presented on an antigenic site of an antigen. CDR3 region of VH in general is 
responsible for antigen-antibody specificity whereas the CDR3 region of VL is 
important for the affinity of the antibody towards the antigen (Zeng et al., 2012).   
 Due to its small size, modification at genetic level is easily introduced. Metal-
binding tags such as histidine and cysteine are directly introduced in its linker 
peptide, leading them to self-assemble on sensor surfaces in the correct conformation 
thus increasing the chances of binding of the antibody to the antigen. Generally, 5-20 
amino acids of glycine(G) and serine(S) are being used to bring VH and VL together 
as a single fragment (Delves et al., 2011). scFv containing less than 15 amino acids 
or without linker amino acid are often unable to fold properly, however they are able 
to link or entwin with other scFv to form diabodies, triabodies, tetramers or tandem 
scFv. These types of metameric scFv together with multivalent antigens are useful in 
increasing the sensitivity of an assay with respect to the increases in affinity and 
avidity of the complex itself (Conroy et al., 2009; Holliger & Hudson, 2005) . Other 
types of modification which can be made is the generation of minibodies; the scFv 
containing constant region of antibodies or conjugation to nanoparticles to generate 
multifunctional scFv for application in diagnostic or therapeutic field.   
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(i) 
 
 
(ii) 
Figure 2.2 Sortase A reaction mechanism (adopted from Theile et al. (2013) (i) 
Structural sketch of reaction mechanism, (ii) Sortase A chemical reaction mechanism  
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2.2.5 Enhanced green fluorescent protein (eGFP) 
Wild type green fluorescent protein(GFP) was first isolated by Shimomura et al. 
(1962) from Aequorea victoria and the sequence was retrieved later in 1992 by 
Prasher et al. (1992).  GFP is a small protein consisting of 238 amino acids sequence 
with a molecular weight ranging from 27-30kDa. This monomeric protein gained 
much interest from researchers since its ultimate discovery. The initial work with 
GFP highlighted a major problem in terms of its low luminescence activity which 
falls below the standard of conventional reporters (Reichel et al., 1996; G. Zhang et 
al., 1996).  
 Due to the highlighted problem, the luminescence and expression of GFP was 
enhanced by introducing mutation to the chromophore of the GFP including codon 
optimization. These so-called GFP variants contain amino acid substitutions at 
position 54 and 66 where Phe
54
 was replaced by Leu and Ser
66
 was replaced by Thr 
(Cormack et al., 1996). Aside from that, almost 200 nucleotide bases of GFP 
underwent silent mutations to suit the preference of the human codon-usage (Haas et 
al., 1996). These enhanced variants of GFP were named as enhanced green 
fluorescent protein (eGFP).  
 In 1994, Chalfie et al. (1994) reported the usage of GFP as a reporter system 
in gene expression. This thought sparked a wave of studies in GFP manipulation as a 
reporter system in diagnostic and therapeutic application. GFP is commonly used as 
fusion partners for visualization of whole cells and even as transcriptional probes 
(March et al., 2003).  In building the screening platform, discovery of GFP provided 
a great impact in providing cost effective and time saving detection system. As a 
biomarker, GFP was used to select the potent CHO cells which maintain the 
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recombinant protein expression under repressed conditions (Yuk et al., 2002), loss of 
fluorescence due to apoptosis in human and mouse cell lines (Strebel et al., 2001), 
and it also contributed to the discovery of the twin-arginine translocation(TAT) 
pathway in E.coli where proteins are folded in the cytoplasm before being 
transported out to periplasm layer (DeLisa et al., 2002). 
 Due to its various applications, GFP variants have been developed in which 
each and every variant shows different excitation and emission spectra from the wild 
type GFP. As observed using FL600 microplate fluorescent reader, red-shifted GFP 
variant has an excitation peak at 488nm and emission peak at 509nm whereas the 
wild type GFP has the excitation peak at 395nm and emission peak at 509nm and the 
blue GFP mutant has an excitation peak at almost 380nm and emission at 460nm. 
The application of GFP can aid to simplify and reduce the time required in a protein 
immunoassay. The fusion reaction between protein A and GFP for bioassay reported 
by Aoki and co-workers had successfully probe the SDS-PAGE gel for the presence 
of recombinant nonspecific enolase (Aoki et al., 1996). After that, the method was 
improved using protein G originating from Streptococcus sp. for targeting a wider 
array of targets for example goat and sheeps IgGs and mouse IgGs (Arai et al., 
1998). The method was then simplified even more by using single molecule 
detection by fusing anti-hepatitis B scFv to eGFP. The developed probes function as 
the fluorescent antibody (Casey et al., 2000). These facts indicate how important 
GFP is to the biotechnological fields because of its aptitude in drug-screening and for 
protein-protein interaction studies.  
 
 
20 
 
2.2.6 Invertase 
Invertase or its other name beta-fructofuranosidase is an enzyme that coverts sucrose 
to glucose via hydrolysis process. It is commonly expressed in various organisms, 
including bacteria, fungi and plants. One good example of sucrose-hydrolysing 
bacteria is Zymomonas mobilis. It is chosen as the best candidate in fermenting 
ethanol, defeating yeast. In Z.mobilis, there are three important sucrose-hydrolyzing 
enzymes, known as invA, invB and levansucrase (Buchholz & Eveleigh, 1990; Ohta 
et al., 1991). invA was only found intracellularly, while, invB and levansucrase was 
found in the culture medium of Z. mobilis.  
 More than 60% of sucrose conversion via the bacterial enzyme was catalysed 
by the extracellular invertase (invB) (O'Mullan et al., 1992). Research found that the 
catalytic activity of invB is the highest among the prokaryotic invertases (Bugbee, 
1984; Vega et al., 1991). Besides, the conversion reaction by invertase is highly 
specific as it catalyses its specific substrate only; the β-fructosyl end of a glycosidic 
bond which is commonly seen in sucrose. The product of this enzymatic reaction 
appeared to be only glucose and fructose at equimolar concentration. Although both 
levansucrase and invB are classified under extracellular sucrases, they take a 
different role. InvB do not catalyse the polymerisation of levan and not even take 
part in degradation of polyfructan as seen in Bacillus subtilis levansucrase (Martin et 
al., 1987).   
 InvB is a 47kDa extracellular invertase which was released to culture broth 
and intracellular for its catalytic activity. It is located at the cell surface of the 
bacterial cells (Vásquez-Bahena et al., 2006). The isoelectric point was calculated to 
be at 4.3 and the sucrase activity is at its optimum at pH 5.0-5.5 (O'Mullan et al., 
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1992; Vallejo-Becerra et al., 2008). InvB is the only invertase grouped in 68 families 
of glucosyl hydrolases which most of the family members come from levansucrases 
(Kondo et al., 1994; Kyono et al., 1995). Even though the expression level of invB in 
Zymomonas mobilis was very low, the saccharolytic activity that it has is high level 
compared to any other sucrose. Due to its high saccharolytic activities and 
specificities, invB is chosen as a biomarker in the assay development in recent 
studies (Borman, 2011; Xiang & Lu, 2011, 2013; X. Zhu et al., 2014).  
 
2.3 Escherichia coli as a host cell 
A full understanding on the properties of Escherichia coli strains is crucial in order 
to perform a successful technique in molecular genetics. E.coli has various strains 
which are genetically engineered to be used in the propagation and manipulation of 
recombinant DNA. E.coli exists as a short rod shaped bacteria from Gram negative 
family which contains a circular genome of 4.6 mega base pair. It is favoured as a 
model system due to its short doubling time and ability to grow on various media 
(Blattner et al., 1997). E.coli has a doubling time of 20-30min in a rich media; 
therefore, it would be enough to generate a population of 1-2billion cells per ml of 
liquid media. Besides, the high transformability and the genetic manipulation secure 
its position as a suitable host for propagation, manipulation and also the 
characterization of recombinant DNA.  
 The commonly used E.coli in recombinant DNA technology is mostly 
derived from E.coli K12 strain. This strain was isolated from the faeces of diphtheria 
patient in 1922 (Tatum & Lederberg, 1947).   
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2.3.1 DH10B Escherichia coli strain 
DH10B is a widely used Escherichia coli strain for propagation of large insert DNA 
library clones. Due to its high efficiency of DNA transformation and well 
preservation of large plasmid, it is fully utilized for cloning. Generating the strains 
takes up a series of extensive genetic recombination steps with 226 genes being 
manipulated. Originated from K-12 strain MG1655, mutation rate of this strain was 
observed to be 13.5 fold higher than its original strains suggesting the effect of 
sudden increase in insertion sequence (IS) transposition. Due to the transposition 
activity of IS elements, the genome architecture was remodelled and causing tandem 
duplication and inversion. Due to leuLABCD gene deletion, the strain needs addition 
of leucine to grow on minimal medium. Deletion of both relA1 and spoT1 alleles 
cause the strains to be sensitive to the nutritional deficiencies and grow slightly 
slower compared to the wild types strain (Durfee et al., 2008).  
 MAX Efficiency DH10B
TM
 developed by Life Technologies is a mcrA, mcrB, 
mcrC and mrr strain containing the mutation of mcrA and knockout of the whole 
mrr-hsdRMS-mcrBC region. This modification allows the production of higher 
amount of colonies per microgram of the methylated DNA compared to other strains. 
With the removal of the restriction systems, the chances of getting more clone 
containing methylated cytosine residue is enhanced. Reports also proved that strains 
with mcrA and mcrBC shows increment in efficiency of transformation by more than 
1000-folds compared to DH5ɑ (Lorow & Jessee, 1990).  
 To efficiently clone methylated DNA, a few genetic markers was introduced. 
recA1 was introduced to stabilize the foreign insert, meanwhile endA1 takes the role 
of improving the DNA quality from plasmid isolation. hsdRMS is also mutated to 
23 
 
enable the cloning of DNA conducted in a restriction endonuclease-free 
environment. Besides, φ80dlacZ∆M15 marker also was introduced to allow alpha-
complementation with the β-galactosidase gene from vectors harbouring it for blue-
white screening using X-gal plate (Lorow & Jessee, 1990). Hence, DH10B is a 
suitable host for cloning purpose.  
 
2.3.2 BL21(DE3) 
BL21 host strain is widely used for expression of recombinant protein in bacterial 
expression system (Sorensen & Mortensen, 2005). BL21 (DE3) is a type of 
expression B strain of E.coli. It contain the chromosomal λ DE3 encoding expression 
of T7 RNA polymerase (RNAP) under restrict control of lacUV5 promoter 
(Samuelson, 2011) allowing expression under  tight control of T7 promoter system. 
This B21 derivative has mutation of lon which encodes for lon protease and ompT 
encodes for outer membrane proteases to increase the expression yield and help in 
stabilization for the recombinant protein (Casali, 2003; Samuelson, 2011).  
 
2.3.3 SHuffle T7 K12 
Originates from K-12 strain, SHuffle T7 contains modified genome with trxB and 
gor gene knockout. These genes are the reductases responsible in maintaining 
reduced condition of cytoplasm of E.coli where gor encodes for glutathione 
reductase and trxB encodes for thioredoxin reductase. Mutation of both genes allows 
disulphide bond formation in cytoplasmic region of E.coli (Casali, 2003).  
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 This mutant strain was further modified with constitutive expression of 
disulphide isomerase (DsbC) encoded by dsbC. DsbC is a part of reducing system in 
periplasm of E.coli (McCarthy et al., 2000). It takes a role of correcting the 
misfolded protein by transferring its disulphide bond to the protein by oxidizing the 
protein while it was reduced (Zapun et al., 1995). The insertion of this feature allow 
correct folded protein formation within cytoplasm while ensuring the fidelity of 
disulphide bond as well as  improving the  yield of recombinant proteins.  
 Commonly, scFvs are expressed in cytoplasm and form the disulphide bond in 
periplasm layer where it was trans located with the aids of leader peptide following 
Sec(PelB) (H. Thie et al., 2008) or Tat pathways (TorA) (DeLisa et al., 2002). Using 
this systems, mature form of scFv without leader peptide are achieved after the 
leader peptide was cleaved off upon translocation (Dev & Ray, 1990). Even though 
the system allows correct protein folding in periplasmic layer, it suffers from low 
protein yield due to inefficient translocation (Lobstein et al., 2012; Zarschler et al., 
2013). Disulphide bond in scFv is essential for the stability and functionality of the 
antibodies binding to its antigen (Ahmad et al., 2012; Smallshaw et al., 1999). 
Hence, a cytoplasmic-disulphide bond formation is an ideal to overcome such 
problem under tight control of T7 promoter.   
 
2.4 Expression vector 
2.4.1 pRSET-B 
pRSET-B utilizes the T7 based expression system originally constructed by 
F.William Studier and his group in 1990 (Studier et al., 1990). It is a widely used 
system for high level recombinant protein expressions adapted from T7 RNA 
